![Ulrich Blaschke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ulrich Blaschke
Directeur Technique/Scientifique/R&D chez
NYKODE THERAPEUTICS
Profil
Ulrich Blaschke currently works at Eferest GmbH, as Chief Executive Officer and Nykode Therapeutics ASA, as Chief Technology Officer from 2024.
Dr. Blaschke received his doctorate degree from The Rockefeller University.
Postes actifs de Ulrich Blaschke
| Sociétés | Poste | Début |
|---|---|---|
| NYKODE THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/01/2024 |
Eferest GmbH
 Eferest GmbH Industrial MachineryProducer Manufacturing Manufactures pressure vessels and pressure-retaining parts | Directeur Général | - |
Formation de Ulrich Blaschke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
Eferest GmbH
Eferest GmbH Industrial MachineryProducer Manufacturing Manufactures pressure vessels and pressure-retaining parts | Producer Manufacturing |
